Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 30, 2021
Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about!
Via
InvestorPlace
Exposures
Product Safety
ImmunoGen, inc (IMGN) Q3 2021 Earnings Call Transcript
October 29, 2021
IMGN earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Recap: Immunogen Q3 Earnings
October 29, 2021
Immunogen (NASDAQ:IMGN) reported its Q3 earnings results on Friday, October 29, 2021 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Scheduled For October 29, 2021
October 29, 2021
Companies Reporting Before The Bell • Sify Technologies (NASDAQ:SIFY) is expected to report quarterly earnings at $0.02 per share on revenue of $97.70 million. •...
Via
Benzinga
Earnings Outlook For Immunogen
October 28, 2021
Immunogen (NASDAQ:IMGN) is set to give its latest quarterly earnings report on Friday, 2021-10-29. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
ImmunoGen, inc (IMGN) Q2 2021 Earnings Call Transcript
July 30, 2021
IMGN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Recap: Immunogen Q2 Earnings
July 30, 2021
Shares of Immunogen (NASDAQ:IMGN) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 7.14% year over year to ($0.15),...
Via
Benzinga
Earnings Scheduled For July 30, 2021
July 30, 2021
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter. • Embraer (NYSE:ERJ) is...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Immunogen Insights: Return On Capital Employed
June 23, 2021
Immunogen (NASDAQ:IMGN) reported Q1 sales of $15.71 million. Earnings fell to a loss of $28.92 million, resulting in a 179.18% decrease from last quarter. Immunogen earned $36.52...
Via
Benzinga
Immunogen Insights: Return On Capital Employed
June 07, 2021
Immunogen (NASDAQ:IMGN) reported Q1 sales of $15.71 million. Earnings fell to a loss of $28.92 million, resulting in a 179.18% decrease from last quarter. Immunogen earned $36.52...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Immunogen Inc (IMGN) Q1 2021 Earnings Call Transcript
May 10, 2021
IMGN earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Immunogen: Q1 Earnings Insights
May 10, 2021
Shares of Immunogen (NASDAQ:IMGN) decreased 1.8% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were unchanged 0.00% over...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.